Intellectual property law

Permianville Royalty Trust Announces Monthly Operational Update

Retrieved on: 
Friday, July 16, 2021
Energy, Professional services, Oil, Gas, Finance, Law, Legal entities, Articles, Expense, Intellectual property law, Patent law, Royalty payment, Trust law, Royalty trust, Oil and gas law in the United States, Energy

The remaining administrative advances for the prior months will be repaid with any net profits in next months net profits interest calculation.

Key Points: 
  • The remaining administrative advances for the prior months will be repaid with any net profits in next months net profits interest calculation.
  • Permianville Royalty Trust is a Delaware statutory trust formed to own a net profits interest representing the right to receive 80% of the net profits from the sale of oil and natural gas production from certain, predominantly non-operated, oil and gas properties in the states of Texas, Louisiana and New Mexico.
  • In addition, future monthly capital expenditures may exceed the average levels experienced in 2020 and prior periods.
  • Neither the Sponsor nor the Trustee intends, and neither assumes any obligation, to update any of the statements included in this press release.

transcosmos's affiliated company UNQ, a leading Chinese e-commerce solutions provider launches IPO in HKEX main board

Retrieved on: 
Friday, July 16, 2021
Trademark law, Intellectual property law, Brand management, Product management, Marketing, Intangible assets, Trademark, Registered trademark symbol, Canadian trademark law

*transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.

Key Points: 
  • *transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
  • *Other company names and product or service names used here are trademarks or registered trademarks of respective companies.
  • *Other company names and product or service names used here are trademarks or registered trademarks of respective companies.
  • *This press release is for information purposes only and should not be construed as investment advice or an offer or solicitation to buy or sell securities.

Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update

Retrieved on: 
Friday, July 16, 2021
Expense, Intellectual property law, Patent law, Royalty payment, NicOx

The number of prescriptions1 for VYZULTA in the U.S. increased by 21% in the second quarter of 2021 compared to the second quarter of 2020.

Key Points: 
  • The number of prescriptions1 for VYZULTA in the U.S. increased by 21% in the second quarter of 2021 compared to the second quarter of 2020.
  • The number of ZERVIATE U.S. prescriptions1 increased by 712% in the second quarter of 2021 over the second quarter of 2020.
  • Net revenue2 for the second quarter of 2021 was 0.7 million (including 0.6 million of net royalty payments).
  • Nicox disavows any obligation to correct or to update the information contained in analyst reports.

Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond

Retrieved on: 
Thursday, July 15, 2021
Articles, Ethics, Ethical investment, Intellectual property law, Legorreta, Royalty Pharma, Bond, Corporate social responsibility, International Capital Market Association, Royalty payment

Royalty Pharma intends to use the net proceeds from the 2051 Notes for general corporate purposes.

Key Points: 
  • Royalty Pharma intends to use the net proceeds from the 2051 Notes for general corporate purposes.
  • Royalty Pharma has developed a Social Bond Framework aligned with the International Capital Market Associations Social Bond Principles, 2021, which are voluntary guidelines that promote transparency and integrity in the social bond market.
  • ISS ESG has reviewed that Royalty Pharmas Social Bond Framework aligns with the Social Bond Principles issued by the International Capital Markets Association.
  • We are pleased to announce the pricing of our first ever Social Bond, underscoring our strong commitment to corporate social responsibility, stated Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma.

Barrick On Course to Achieve 2021 Production Targets

Retrieved on: 
Thursday, July 15, 2021
Expense, Intellectual property law, Patent law, Royalty payment, Barrick, Reconciliation, S&P/TSX 60, Barrick Gold

C1 cash costs per pound excludes royalties and production taxes and non-routine charges as they are not direct production costs.

Key Points: 
  • C1 cash costs per pound excludes royalties and production taxes and non-routine charges as they are not direct production costs.
  • Barrick will provide a full reconciliation of these non-GAAP financial measures when the Company reports its quarterly results on August9, 2021.
  • Barrick will provide additional discussion and analysis and other important information about its second quarter production levels and sales and associated costs when it reports actual results on August9, 2021.
  • Barrick also cautions that its 2021 guidance may be impacted by the unprecedented business and social disruption caused by the spread of Covid-19.

Iveda Announces Engagement with a PCAOB Auditor to Uplist Back to OTCQB Fully Reporting Status

Retrieved on: 
Thursday, July 15, 2021
Intellectual property law, Intangible assets, Brand management, Brands, Product management, Trademark, Marketing, Homeland security, Market economics)

Iveda is constantly on the move with exciting achievements every day from new revenues to new products and new technologies.

Key Points: 
  • Iveda is constantly on the move with exciting achievements every day from new revenues to new products and new technologies.
  • Iveda and Sentir are registered trademarks of Iveda Solutions, Inc. IvedaAI, IvedaPinpoint and IvedaHome are trademarks of Iveda Solutions, Inc. All other trademarks are property of their respective owners.
  • Iveda has a SAFETY Act Certification from the U.S. Department of Homeland Security as a Qualified Anti-Terrorism Technology Provider.
  • All forward-looking statements made herein are qualified by such risk factors, and readers are advised to consider such factors carefully.

Verde Bio Holdings, Inc. Announces Opportunistic Divestiture of Assets

Retrieved on: 
Thursday, July 15, 2021
Expense, Intellectual property law, Patent law, Royalty payment

Verde Bio Holdings will achieve approximately 84 percent profit after holding this asset for a little more than three months.

Key Points: 
  • Verde Bio Holdings will achieve approximately 84 percent profit after holding this asset for a little more than three months.
  • In addition to the profits from sale, Verde also will receive all revenue of the assets related to production from the wells from March 1, 2021, to July 31, 2021, estimated to be approximately $80,000.
  • We are going to be opportunistic for our shareholders when the situation, such as this, necessitates it.
  • About Verde Bio Holdings, Inc.: Verde Bio Holdings, Inc. (OTC: VBHI), is a U.S. Energy Company based in Frisco, Texas, engaged in the acquisition and management of Mineral and Royalty interests in lower risk, onshore oil and gas properties within the major oil and gas plays in the U.S.

XOMA Acquires Royalty and Milestone Interest in Checkmate’s Vidutolimod (CMP-001) from Kuros Biosciences

Retrieved on: 
Thursday, July 15, 2021
Health sciences, Pharmaceutical sciences, Life sciences, Pharmaceutical industry, Expense, Intellectual property law, Patent law, Royalty payment, Medication, Gevokizumab

We were drawn to vidutolimod because of the breadth of Checkmates development activities, said Jim Neal, Chief Executive Officer at XOMA.

Key Points: 
  • We were drawn to vidutolimod because of the breadth of Checkmates development activities, said Jim Neal, Chief Executive Officer at XOMA.
  • Kuros will be eligible to receive certain sales milestone payments from XOMA based on net sales of vidutolimod.
  • XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
  • As of the date of this press release, all assets in XOMAs milestone and royalty portfolio, including vidutolimod, are investigational compounds.

Aware Sets Second Quarter 2021 Conference Call for Tuesday, July 27, 2021 at 5:00 p.m. Eastern Time

Retrieved on: 
Thursday, July 15, 2021
Brand management, Brands, Intellectual property law, Product management, Trademark, Marketing, Market economics)

Aware management will host the webcast presentation, followed by a question-and-answer session.

Key Points: 
  • Aware management will host the webcast presentation, followed by a question-and-answer session.
  • The presentation will be made available for replay in the investor relations section of the Companys website .
  • Aware serves customers across a multitude of industries, including financial services, enterprise security, healthcare, human resources, citizen ID, border management, law enforcement, defense, and intelligence.
  • Aware is a registered trademark of Aware, Inc.

USPTO Awards SproutLoud Patent for Change Management System in Co-Op Marketing

Retrieved on: 
Thursday, July 15, 2021
Marketing, Data management, Communications, Technology, Other Technology, Software, Intangible assets, Intellectual property law, Marketing, Intellectual property organizations, Patent offices, Marketing automation, Trademark, Patent, United States Patent and Trademark Office

Marketing technology company SproutLoud is proud to announce that it has been awarded a second patent from the United States Patent and Trademark Office (USPTO), protecting its innovative distributed marketing ecosystems.

Key Points: 
  • Marketing technology company SproutLoud is proud to announce that it has been awarded a second patent from the United States Patent and Trademark Office (USPTO), protecting its innovative distributed marketing ecosystems.
  • This new patent specifically covers SproutLouds Co-Op Marketing model, which supports change management by helping clients move from reimbursement systems to co-pay.
  • SproutLoud has been thoughtful about how it institutes change for Co-Op Marketing systems.
  • SproutLoud built its change management process and associated features into its proprietary marketing technology stack, which is a significant differentiation within the Through Channel Marketing Automation industry.